Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bladder Cancer
Investigators at University of Texas zero in on bladder cancer
April 1st, 2008
According to recent research from the United States, "Although the incidence of bladder cancer lags behind that of other malignancies, it has the highest rate of recurrence among all US malignancies. The propensity to recur and the possibility of disease progression require aggressive surveillance, which has led to bladder cancer being the most expensive malignancy to treat in the United States." "Current non-tailored surveillance strategies applied uniformly to all patients with non-muscle invasive bladder cancer may impose excessive diagnostic burden on patients with low-grade disease for the sake of adequately monitoring those with potentially aggressive disease. The...
Source: Cancer Weekly (2008-04-01)
|
